Trial intelligence / Profile preview

Collaborative Care for Alcohol Use Disorders in Primary Care

NCT02885311Phase 2Completed

Sponsor
Northwell Health
Start
Jan 2017
Primary completion
Oct 2018
Countries
1
01

Overview

A Phase 2 trial of naltrexone in alcohol use disorder (AUD), sponsored by Northwell Health. Started Jan 2017; status: completed.

02

Drugs

naltrexone
03

Conditions

alcohol use disorder (AUD)

Beyond the preview

Go deeper on NCT02885311.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02885311.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call